Sukul, Nidhi
,
Zhao, Junhui
Fuller, Douglas S.
Karaboyas, Angelo
Bieber, Brian
Sloand, James A.
Subramanian, Lalita
Johnson, David W.
Oliver, Matthew J.
Tungsanga, Kriang
Tomo, Tadashi
Morton, Rachael L.
Morgenstern, Hal
Robinson, Bruce M.
Perl, Jeffrey
Funding for this research was provided by:
Amgen (unknown)
Kyowa Hakko Kirin (unknown)
Baxter Healthcare Corporation (unknown)
Article History
Received: 20 September 2018
Accepted: 20 March 2019
First Online: 2 April 2019
Ethics approval and consent to participate
: As detailed under Methods: The PDOPPS was approved by a central institutional review board (IRB) in the US, with IRB study approval and patient consent obtained for each patient, as required by national and local ethics committee regulations.Data from US patients receiving care at large dialysis organization (LDO) sites are imported from electronic health records; data from non-LDO US and non-US patients were obtained from manual medical chart abstraction and entered into a web-based data collection tool.Patient-reported advantages and disadvantages of PD were collected using the PDOPPS PQ, which was mailed to each facility participating in the PDOPPS. All patients who were consented into the PDOPPS were then asked by the facility’s research coordinator or nurse to complete the questionnaire at the time the patient visited the facility for their routine visit. Completing this was voluntary, and patients were able to participate in the study without completing the questionnaire.
: Please see above section, “Ethics Approval and Consent to Participate.”
: Jeff Perl has received speaking honoraria from Baxter Healthcare, Fresenius Medical Care, Davita Healthcare Partners, and consulting fees from Baxter Healthcare, Fresenius Medical Care, as well as unrestricted research support from Baxter Healthcare and salary support from Arbor Research Collaborative for Health.David Johnson has previously received consultancy fees, research grants, travel sponsorships and speaker’s honoraria from Baxter Healthcare and Fresenius Medical Care. He has also received consultancy fees from Astra Zeneca and travel sponsorships from Amgen. He is a current recipient of an Australian National Health and Medical Research Council Practitioner Fellowship.The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.